Cargando…
Stem Cells: Current Status and Therapeutic Implications
Cancer stem cells (CSCs) are a class of pluripotent cells that have been observed in most types of cancers. Evolving evidence suggests that CSCs, has the ability to self-renew and initiate tumors, may be responsible for promoting therapeutic resistance, tumor recurrence and metastasis. Tumor heterog...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699792/ https://www.ncbi.nlm.nih.gov/pubmed/33233552 http://dx.doi.org/10.3390/genes11111372 |
_version_ | 1783616131390504960 |
---|---|
author | Reddy, Kaladhar B. |
author_facet | Reddy, Kaladhar B. |
author_sort | Reddy, Kaladhar B. |
collection | PubMed |
description | Cancer stem cells (CSCs) are a class of pluripotent cells that have been observed in most types of cancers. Evolving evidence suggests that CSCs, has the ability to self-renew and initiate tumors, may be responsible for promoting therapeutic resistance, tumor recurrence and metastasis. Tumor heterogeneity is originating from CSCs and its progenitors are recognized as major difficulty in efficaciously treating cancer patients. Therefore, understanding the biological mechanisms by which CSCs survive chemo- and-radiation therapy has the potential to identify new therapeutic strategies in the future. In this review, we summarized recent advances in CSC biology and their environment, and discuss about the potential therapies to prevent therapeutic resistance. |
format | Online Article Text |
id | pubmed-7699792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76997922020-11-29 Stem Cells: Current Status and Therapeutic Implications Reddy, Kaladhar B. Genes (Basel) Review Cancer stem cells (CSCs) are a class of pluripotent cells that have been observed in most types of cancers. Evolving evidence suggests that CSCs, has the ability to self-renew and initiate tumors, may be responsible for promoting therapeutic resistance, tumor recurrence and metastasis. Tumor heterogeneity is originating from CSCs and its progenitors are recognized as major difficulty in efficaciously treating cancer patients. Therefore, understanding the biological mechanisms by which CSCs survive chemo- and-radiation therapy has the potential to identify new therapeutic strategies in the future. In this review, we summarized recent advances in CSC biology and their environment, and discuss about the potential therapies to prevent therapeutic resistance. MDPI 2020-11-20 /pmc/articles/PMC7699792/ /pubmed/33233552 http://dx.doi.org/10.3390/genes11111372 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Reddy, Kaladhar B. Stem Cells: Current Status and Therapeutic Implications |
title | Stem Cells: Current Status and Therapeutic Implications |
title_full | Stem Cells: Current Status and Therapeutic Implications |
title_fullStr | Stem Cells: Current Status and Therapeutic Implications |
title_full_unstemmed | Stem Cells: Current Status and Therapeutic Implications |
title_short | Stem Cells: Current Status and Therapeutic Implications |
title_sort | stem cells: current status and therapeutic implications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699792/ https://www.ncbi.nlm.nih.gov/pubmed/33233552 http://dx.doi.org/10.3390/genes11111372 |
work_keys_str_mv | AT reddykaladharb stemcellscurrentstatusandtherapeuticimplications |